Skip to main content
Top
Published in: Clinical and Translational Oncology 2/2015

01-02-2015 | Brief Research Article

Implementation and assessment of a fast-track programme to improve communication between primary and specialized care in patients with suspected cancer: how to shorten time between initial symptoms of cancer, diagnosis and initiation of treatment

Authors: M. T. Martínez, I. González, N. Tarazona, S. Roselló, R. Saiz, A. Sanmartín, Á. Martínez-Agulló, A. Caballero, P. Mas, J. Franco, J. Martínez-Jabaloyas, J. García-Callejo, V. Martín, J. Navarro, A. Teruel, A. Lluch, I. Chirivella

Published in: Clinical and Translational Oncology | Issue 2/2015

Login to get access

Abstract

Purpose

This study aims to asses a cancer fast-track programme (CFP) to shorten the time since a patient with suspicion of cancer is referred by the primary care (PC) physician to the specialized medical team.

Methods

Guidelines for main suspected tumours were designed to help PC physicians to detect and rapidly refer cases to the CFP oncology coordinator, who sent them to the appropriate department to accelerate diagnosis, staging and therapy. All patients analysed in this report were referred from June 2009 to July 2012.

Results

A total of 897 suspected cancer cases were submitted and finally 705 were studied. In 205 (29 %) a cancer diagnosis was confirmed within 23 days (median). Therapy was initiated within 46 days after referral (median). Early diagnoses with a potential curative approach were made in 166 (82 %).

Conclusions

This CFP decreased the waiting time for cancer diagnosis, by improving communication between PC physician and specialized care teams. Most patients included in this program could get therapy with curative intent.
Literature
2.
go back to reference Bosetti C, Bertuccio P, Malvezzi M, Levi F, Chatenoud L, Negri E, et al. Cancer mortality in Europe, 2005-2009, and an overview of trends since 1980. Ann Oncol. 2013;24(10):2657–71.PubMedCrossRef Bosetti C, Bertuccio P, Malvezzi M, Levi F, Chatenoud L, Negri E, et al. Cancer mortality in Europe, 2005-2009, and an overview of trends since 1980. Ann Oncol. 2013;24(10):2657–71.PubMedCrossRef
3.
go back to reference Sanchez MJ, Payer T, De Angelis R, Larranaga N, Capocaccia R, Martinez C. Cancer incidence and mortality in Spain: estimates and projections for the period 1981−2012. Ann Oncol. 2010;21 Suppl 3:iii30–6.PubMed Sanchez MJ, Payer T, De Angelis R, Larranaga N, Capocaccia R, Martinez C. Cancer incidence and mortality in Spain: estimates and projections for the period 1981−2012. Ann Oncol. 2010;21 Suppl 3:iii30–6.PubMed
4.
go back to reference Ministerio de Sanidad y Política Social. Estrategia en Cáncer del Sistema Nacional de Salud. 2010. Ministerio de Sanidad y Política Social. Estrategia en Cáncer del Sistema Nacional de Salud. 2010.
5.
go back to reference Generalitat Valenciana Conselleria de Sanitat. Plan Oncológico de la Comunidad Valenciana. 2002–2006. Generalitat Valenciana Conselleria de Sanitat. Plan Oncológico de la Comunidad Valenciana. 2002–2006.
6.
go back to reference Macleod U, Mitchell ED, Burgess C, Macdonald S, Ramirez AJ. Risk factors for delayed presentation and referral of symptomatic cancer: evidence for common cancers. Br J Cancer. 2009;101 Suppl 2:S92–101.PubMedCentralPubMedCrossRef Macleod U, Mitchell ED, Burgess C, Macdonald S, Ramirez AJ. Risk factors for delayed presentation and referral of symptomatic cancer: evidence for common cancers. Br J Cancer. 2009;101 Suppl 2:S92–101.PubMedCentralPubMedCrossRef
8.
go back to reference Huebner J, Follmann M. Complementary medicine in guidelines of the German Guideline Program in Oncology: comparison of the evidence base between complementary and conventional therapy. J Cancer Res Clin Oncol. 2013;139(9):1481–8.PubMedCrossRef Huebner J, Follmann M. Complementary medicine in guidelines of the German Guideline Program in Oncology: comparison of the evidence base between complementary and conventional therapy. J Cancer Res Clin Oncol. 2013;139(9):1481–8.PubMedCrossRef
9.
go back to reference Morris EJ, Whitehouse LE, Farrell T, Nickerson C, Thomas JD, Quirke P, et al. A retrospective observational study examining the characteristics and outcomes of tumours diagnosed within and without of the English NHS Bowel Cancer Screening Programme. Br J Cancer. 2012;107(5):757–64.PubMedCentralPubMedCrossRef Morris EJ, Whitehouse LE, Farrell T, Nickerson C, Thomas JD, Quirke P, et al. A retrospective observational study examining the characteristics and outcomes of tumours diagnosed within and without of the English NHS Bowel Cancer Screening Programme. Br J Cancer. 2012;107(5):757–64.PubMedCentralPubMedCrossRef
10.
go back to reference Ascunce N, Salas D, Zubizarreta R, Almazan R, Ibanez J, Ederra M. Cancer screening in Spain. Ann Oncol. 2010;21 Suppl 3:iii43–51.PubMed Ascunce N, Salas D, Zubizarreta R, Almazan R, Ibanez J, Ederra M. Cancer screening in Spain. Ann Oncol. 2010;21 Suppl 3:iii43–51.PubMed
11.
go back to reference Camps C, Iranzo V, Caballero C, Blasco A, Godes MJ, Safont MJ, et al. Oncology outside hospital: a new experience for the benefit of longer survivors. Clin Transl Oncol. 2011;13(4):249–53.PubMedCrossRef Camps C, Iranzo V, Caballero C, Blasco A, Godes MJ, Safont MJ, et al. Oncology outside hospital: a new experience for the benefit of longer survivors. Clin Transl Oncol. 2011;13(4):249–53.PubMedCrossRef
12.
go back to reference Anoz-Jiménez L, Torres-García RM. Coordinación internivel: proceso clave para la calidad asistencial. Aten Primaria. 2008;40(6):314–5. Anoz-Jiménez L, Torres-García RM. Coordinación internivel: proceso clave para la calidad asistencial. Aten Primaria. 2008;40(6):314–5.
13.
go back to reference Bellmunt J, Orsola A, Wiegel T, Guix M, De Santis M, Kataja V. Bladder cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2011;22 Suppl 6:vi45–9.PubMed Bellmunt J, Orsola A, Wiegel T, Guix M, De Santis M, Kataja V. Bladder cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2011;22 Suppl 6:vi45–9.PubMed
14.
go back to reference Field JK, Oudkerk M, Pedersen JH, Duffy SW. Prospects for population screening and diagnosis of lung cancer. Lancet. 2013;382(9893):732–41.PubMedCrossRef Field JK, Oudkerk M, Pedersen JH, Duffy SW. Prospects for population screening and diagnosis of lung cancer. Lancet. 2013;382(9893):732–41.PubMedCrossRef
15.
go back to reference Singh P, Warnakulasuriya S. The two-week wait cancer initiative on oral cancer; the predictive value of urgent referrals to an oral medicine unit. Br Dent J. 2006;201(11):717–20 (Discussion 4).PubMedCrossRef Singh P, Warnakulasuriya S. The two-week wait cancer initiative on oral cancer; the predictive value of urgent referrals to an oral medicine unit. Br Dent J. 2006;201(11):717–20 (Discussion 4).PubMedCrossRef
16.
go back to reference Thistlethwaite J, Stewart RA. Clinical breast examination for asymptomatic women—exploring the evidence. Aust Fam Physician. 2007;36(3):145–50.PubMed Thistlethwaite J, Stewart RA. Clinical breast examination for asymptomatic women—exploring the evidence. Aust Fam Physician. 2007;36(3):145–50.PubMed
17.
go back to reference Wright TC Jr, Cox JT, Massad LS, Carlson J, Twiggs LB, Wilkinson EJ. 2001 consensus guidelines for the management of women with cervical intraepithelial neoplasia. Am J Obstet Gynecol. 2003;189(1):295–304.PubMedCrossRef Wright TC Jr, Cox JT, Massad LS, Carlson J, Twiggs LB, Wilkinson EJ. 2001 consensus guidelines for the management of women with cervical intraepithelial neoplasia. Am J Obstet Gynecol. 2003;189(1):295–304.PubMedCrossRef
18.
go back to reference Nelson HD, Tyne K, Naik A, Bougatsos C, Chan B, Nygren P, et al. Screening for breast cancer: systematic evidence review update for the US preventive services task force. Ann Intern Med. 2009;151(10):727–37. Nelson HD, Tyne K, Naik A, Bougatsos C, Chan B, Nygren P, et al. Screening for breast cancer: systematic evidence review update for the US preventive services task force. Ann Intern Med. 2009;151(10):727–37.
19.
go back to reference Franco Hidalgo S, Prieto de Paula JM, Martín Serradilla JI, Martín Carbayo JL. Unidades de diagnóstico rápido o consultas de atención inmediata en medicina interna. Análisis de los primeros 6 meses de funcionamiento en Palencia. SEMERGEN. 2012;38(2):128–30.CrossRef Franco Hidalgo S, Prieto de Paula JM, Martín Serradilla JI, Martín Carbayo JL. Unidades de diagnóstico rápido o consultas de atención inmediata en medicina interna. Análisis de los primeros 6 meses de funcionamiento en Palencia. SEMERGEN. 2012;38(2):128–30.CrossRef
20.
go back to reference Torne Cachot J, Encinas Mendez X, Vidal Balana JM, Baucells Azcona JM. Multidisciplinary model of an early diagnosis outpatients unit. Med Clin (Barc). 2011;136(3):129–30. Torne Cachot J, Encinas Mendez X, Vidal Balana JM, Baucells Azcona JM. Multidisciplinary model of an early diagnosis outpatients unit. Med Clin (Barc). 2011;136(3):129–30.
Metadata
Title
Implementation and assessment of a fast-track programme to improve communication between primary and specialized care in patients with suspected cancer: how to shorten time between initial symptoms of cancer, diagnosis and initiation of treatment
Authors
M. T. Martínez
I. González
N. Tarazona
S. Roselló
R. Saiz
A. Sanmartín
Á. Martínez-Agulló
A. Caballero
P. Mas
J. Franco
J. Martínez-Jabaloyas
J. García-Callejo
V. Martín
J. Navarro
A. Teruel
A. Lluch
I. Chirivella
Publication date
01-02-2015
Publisher
Springer Milan
Published in
Clinical and Translational Oncology / Issue 2/2015
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-014-1209-3

Other articles of this Issue 2/2015

Clinical and Translational Oncology 2/2015 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine